MedImmune vs. Genentech: Supreme Court Ruling Facilitates Patent Challenges (SeekingAlpha via Yahoo! Finance)
MedImmune vs. Genentech: Supreme Court Ruling Facilitates Patent Challenges (SeekingAlpha via Yahoo! Finance)
Aaron F. Barkoff submits: The U.S. Supreme Court handed down its highly anticipated decision in MedImmune v. Genentech today, holding by an 8-1 majority that a patent licensee is not required to terminate its license agreement before seeking a declaratory judgment that the subject patent is invalid, unenforceable, or not infringed.